Charles Schwab Investment Management Inc Vera Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 351,088 shares of VERA stock, worth $15.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
351,088
Previous 338,425
3.74%
Holding current value
$15.3 Million
Previous $14.6 Million
12.95%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VERA
# of Institutions
182Shares Held
54.7MCall Options Held
42.2KPut Options Held
121K-
Avoro Capital Advisors LLC New York, NY4.31MShares$187 Million2.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.62MShares$157 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$145 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$129 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$121 Million5.61% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.17B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...